01.01.2015 Views

Annals of Diagnostic Paediatric Pathology

Annals of Diagnostic Paediatric Pathology

Annals of Diagnostic Paediatric Pathology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Annals</strong> <strong>of</strong> <strong>Diagnostic</strong> <strong>Paediatric</strong> <strong>Pathology</strong> 2004, 8(3-4):<br />

© Copyright by Polish <strong>Paediatric</strong> <strong>Pathology</strong> Society<br />

<strong>Pathology</strong> <strong>of</strong> fatty liver in children with LCHAD deficiency<br />

Katarzyna Iwanicka 1 , Janusz Ksi¹¿yk 2 , Monika Pohorecka 3 , Maciej Pronicki 1<br />

<strong>Annals</strong> <strong>of</strong><br />

<strong>Diagnostic</strong><br />

<strong>Paediatric</strong><br />

<strong>Pathology</strong><br />

1<br />

Department <strong>of</strong> <strong>Pathology</strong>,<br />

2<br />

The Clinic <strong>of</strong> Pediatrics,<br />

3<br />

Department <strong>of</strong> Metabolic Diseases,<br />

The Children’s Memorial Health Institute,<br />

Warsaw, Poland<br />

Abstract<br />

Deficiency <strong>of</strong> long chain 3-hydroksyacyl-CoA dehydrogenase (LCHADD) impairs the process <strong>of</strong> mitochondrial<br />

beta-oxidation <strong>of</strong> fatty acids. LCHADD may be clinically benign up to the moment <strong>of</strong> first symptoms,<br />

i.e. fasting inducing the first acute life-threatening episode (ALTE). Patients present vomiting, lethargy, convulsions,<br />

arrhytmia and hypoketotic hypoglycemia, which is essential for established a diagnosis. Thus, after<br />

fasting, healthy looking child may die with serious symptoms <strong>of</strong> acute illness. The aim <strong>of</strong> this study was the<br />

histopathological assessment <strong>of</strong> liver in our own LCHADD patients with particular attention to characteristic<br />

changes including intensity, type and localization <strong>of</strong> liver steatosis. Seven liver samples were assessed: 3<br />

biopsies and 4 autopsy specimens obtained from 6 patients, aged from 3 months to one year. In 3 autopsies<br />

we found severe macrovacuolar fatty liver, in one biopsy moderate mixed steatosis, and in remaining 3 cases<br />

mild fatty liver <strong>of</strong> macrovacuolar and mixed character. All samples but one displayed diffuse distribution <strong>of</strong><br />

steatotic hepatocytes. In 4 cases steatosis was accompanied by fibrosis and cirrhosis, in 3 by inflammatory<br />

infiltrates. Intensity <strong>of</strong> steatosis was related to the severity <strong>of</strong> clinical symptoms. Fibrosis was another morphological<br />

feature characteristic for LCHAD deficiency. The results showed that liver steatosis found during<br />

autopsy <strong>of</strong> patients who died <strong>of</strong> unexplained reason should attract attention to LCHADD as a possible cause<br />

<strong>of</strong> death.<br />

Key words: LCHAD deficiency, liver steatosis<br />

Introduction<br />

Clinical symptoms <strong>of</strong> long chain 3-hydroksyacyl-CoA dehydrogenase<br />

(LCHAD) deficiency usually appear after prolonged<br />

fasting or could be evoked by upper respiratory tract infections,<br />

vaccination, physical exercises and other stress. Clinically<br />

healthy child presents hypoketotic hypoglycemia, which<br />

may be accompanied by vomiting, abdominal pain, convulsion,<br />

muscle weakness and cardiomegaly. In the course <strong>of</strong> the<br />

disease sensorimotor neuropathy and pigmentary retinopathy<br />

develop [5, 9, 11]. The age <strong>of</strong> onset ranges from one day to 40<br />

months. Treatment involves the diet with long chain fatty acids<br />

restriction and increased supply <strong>of</strong> carbohydrates.<br />

Fatty acids are the most important source <strong>of</strong> energy<br />

during fasting [5, 11]. They are transported into the inner<br />

membrane <strong>of</strong> mitochondria to be used in beta-oxidation process<br />

[5, 9, 11]. This process has especially important value<br />

for muscle, heart and liver cells as their own source <strong>of</strong> energy.<br />

Beta-oxidation process has two steps: transport and following<br />

oxidation. Three enzymes take parts in transport <strong>of</strong> fatty<br />

acids into the mitochondria, creating the pathway called carnitine<br />

transporting system [2, 3, 5, 12]. Proper beta-oxidation<br />

pathway depends on activity <strong>of</strong> several enzymes (four for long,<br />

four <strong>of</strong> medium and four for short chain fatty acids). The names<br />

<strong>of</strong> appropriate enzymes differ only by the name <strong>of</strong> length <strong>of</strong><br />

the chain. The basis <strong>of</strong> beta-oxidation process is shortening <strong>of</strong><br />

fatty acid chain by cutting acetyl-CoA to introduce it to tricarboxylic<br />

acids cycle. Deficiency <strong>of</strong> 3-hydroksyacyl-CoA dehydrogenase<br />

(LCHAD) impairs the process and leads to toxic<br />

accumulation <strong>of</strong> fatty acids and their acylcarnitines derivatives<br />

[2, 5, 7, 9, 11]. Accumulation <strong>of</strong> lipids in the cells may<br />

be a site effect <strong>of</strong> this metabolic decompensation.<br />

Address for correspondence<br />

Iwanicka Katarzyna<br />

Department <strong>of</strong> <strong>Pathology</strong><br />

The Children's Memorial Health Institute<br />

Aleja Dzieci Polskich 20,<br />

04-736 Warsaw, Poland<br />

Phone: +48 22 815 16 14<br />

E-mail: kasiai@yahoo.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!